29 August 2025

---

Sonendo Reports Q2 2025 Results, Reaffirms Guidance

---

Sonendo, Inc., a leading dental technology company and developer of the GentleWave System, announced select financial results for the quarter ended June 30, 2025, and reaffirmed its full-year guidance.

The company reported Q2 revenue of $7.4 million, down 11% from the prior year, a decline attributed to fewer console sales through a smaller, more cost-efficient sales team. Despite lower sales, gross margin rose to 41%, an improvement of 320 basis points year-over-year. Loss from continuing operations decreased by $3.6 million to $3.9 million, and adjusted EBITDA loss improved 47% to $3.0 million. Free cash flow burn dropped 61% to $2.6 million.

CEO Bjarne Bergheim highlighted the company’s focus on selling consoles more efficiently while increasing procedure instrument utilization. He noted efforts to make the commercial team more responsive to customer and patient needs, as well as recent improvements to liquidity. Bergheim emphasized Sonendo’s commitment to operational excellence and positioning the company for long-term profitable growth.

As of June 30, 2025, Sonendo held $9.3 million in cash, cash equivalents, and short-term investments, with $14.2 million in principal outstanding under its credit facility.

The company reaffirmed its 2025 guidance:

• Revenue: $31–$32 million
• GAAP Gross Margin: 44%–46%
• Adjusted EBITDA: $(11)–$(14) million
• Free Cash Flow: $(12)–$(15) million

Sonendo develops and manufactures the GentleWave System, an advanced technology for root canal therapy that uses fluid optimization, acoustic energy, and fluid dynamics to clean and disinfect teeth while preserving structure. The system aims to improve clinical outcomes, speed healing, reduce post-operative pain, and enhance dental practice efficiency.

Source: www.sonendo.com